{"nct_id":"NCT04637763","title":"CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)","status":"RECRUITING","status_verified_date":"2024-05","start_date":"2021-05-26","start_date_type":"ACTUAL","primary_completion_date":"2025-08","primary_completion_date_type":"ESTIMATED","completion_date":"2025-09","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["CRBU"]}